Perlara PBC
General Information
BounceWatch is an independent company data service, not affiliated with Perlara PBC. To contact Perlara PBC, visit perlara.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Perlara PBC compare?
A PDF of Perlara PBC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Perlara PBC soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Biotechnology
About Perlara PBC
Business keywords: biotech, precision drug discovery, rare genetic diseases, CRISPR-engineered animal models, lysosomal storage disorders, Niemann-Pick Type C, NGLY1 Deficiency, mitochondrial diseases, peroxisomal biogenesis disorders, drug development, public benefit corporation, startup, investing, genetic research
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $4.14M | - |
|
18 Aug 2017 |
| Series A | Undisclosed | 1 |
|
02 Nov 2016 |
| Seed Round | $120.00K | 2 |
|
22 Mar 2016 |
| Seed Round | $2.50M | - |
|
10 Apr 2015 |
| Seed Round | $2.20M | - |
|
31 Oct 2014 |
| Seed Round | $2.80M | 2 |
|
31 Jul 2014 |
Perlara PBC Alternatives & Competitors
Developing small molecule drugs for genetic diseases..
Advance Graphene-Based Technology to Save and Improve People's Lives
Unfolding the next generation of allosteric small molecule therapies to meet patient needs
FAQ About Perlara PBC
Source: BounceWatch company record for Perlara PBC, https://bouncewatch.com/company/perlara-pbc, updated 27 December 2024. When citing, please name BounceWatch and link this page.
